An alternate delivery system improves vaccine performance against foot-and-mouth disease virus (FMDV)

Vaccine

Volumn 30, Issue 20, 2012, Pages 3106-3111

  Pandya, Mital ^a   Pacheco, Juan M ^a   Bishop, Elizabeth ^a   Kenney, Mary ^a   Milward, Francis ^b   Doel, Timothy ^b   Golde, William T ^a  

^a PLUM ISLAND ANIMAL DISEASE CENTER   (United States)

^b BOEHRINGER INGELHEIM PHARMA GMBH AND CO KG   (Germany)

Author keywords

FMDV; Immune response; Intradermal; Vaccination; Virus

Indexed keywords

FOOT AND MOUTH DISEASE VACCINE;

ANIMAL EXPERIMENT; ARTICLE; CATTLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RESPONSE; FOOT AND MOUTH DISEASE; FOOT AND MOUTH DISEASE VIRUS; INFECTION PREVENTION; MALE; NONHUMAN; PRIORITY JOURNAL; VACCINATION;

ANIMALS; CATTLE; CATTLE DISEASES; DRUG DELIVERY SYSTEMS; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; INJECTIONS, INTRADERMAL; VACCINES, INACTIVATED; VIRAL VACCINES;

EID: 84859430605     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2012.02.049     Document Type: Article

References (26)

1. Lee B., Park Jiyoung Gordon Peter Moore I.I., James E., Richardson Harry W. Estimating the state-by-state economic impacts of a foot-and-mouth disease attack. Int Reg Sci Rev 2010, 1-22.
2. Grubman M.J., Baxt B. Foot-and-mouth disease. Clin Microbiol Rev 2004, 17(April (2)):465-493.
3. Eble P.L., Weerdmeester K., van Hemert-Kluitenberg F., Dekker A. Intradermal vaccination of pigs against FMD with 1/10 dose results in comparable vaccine efficacy as intramuscular vaccination with a full dose. Vaccine 2009, 27(February (8)):1272-1278.
4. Golde W.T., Pacheco J.M., Duque H., Doel T., Penfold B., Ferman G.S., et al. Vaccination against foot-and-mouth disease virus confers complete clinical protection in 7 days and partial protection in 4 days: use in emergency outbreak response. Vaccine 2005, (September).
5. Glenn G.M., Kenney R.T. Mass vaccination:solutions in the skin. Curr Top Microbiol Immunol 2006, 304:247-268.
6. Nicolas J.F., Guy B. Intradermal, epidermal and transcutaneous vaccination: from immunology to clinical practice. Expert Rev Vaccines 2008, 7(October (8)):1201-1214.
7. Nfon C.K., Dawson H., Toka F.N., Golde W.T. Langerhans cells in porcine skin. Vet Immunol Immunopathol 2008, 126(December (3-4)):236-247.
8. Foot and Mouth Disease. Manual of standards for diagnostic tests and vaccines. Paris, France, 2009.
9. Narasimhan B., Wilson-Welder J.H., Torres M.P., Kipper M.J., Mallapragada S.K., Wannemuehler M.J. Vaccine adjuvants: current challenges and future approaches. J Pharm Sci US 2009, 98(April (4)):1278-1316.
10. Doel T.R. Natural and vaccine induced immunity to FMD. Curr Top Microbiol Immunol 2005, 288:103-131.
11. Rodriguez L.L., Barrera J., Kramer E., Lubroth J., Brown F., Golde W.T. A synthetic peptide containing the consensus sequence of the G-H loop region of foot-and-mouth disease virus type-O VP1 and a promiscuous T-helper epitope induces peptide-specific antibodies but fails to protect cattle against viral challenge. Vaccine 2003, 21(September (25-26)):3751-3756.
12. Hierholzer J., Killington R.A. Virus Isolation and quantitation virology methods manual 1996, 25-46. Academic Press Inc., San Diego, CA, p. 542.
13. Doel T.R. FMD vaccines. Virus Res 2003, 91(January (1)):81-99.
14. Janeway C.A. Approaching the asymptote? Evolution and revolution in immunology. Cold spring harbor symposia on quantitative biology 1989, pp. 1-13.
15. McCullough K.C., De Simone F., Brocchi E., Capucci L., Crowther J.R., Kihm U. Protective immune response against foot-and-mouth disease. J Virol 1992, 66(April (4)):1835-1840.
16. Callahan J.D., Brown F., Osorio F.A., Sur J.H., Kramer E., Long G.W., et al. Use of a portable real-time reverse transcriptase-polymerase chain reaction assay for rapid detection of foot-and-mouth disease virus. J Am Vet Med Assoc 2002, 220(June (11)):1636-1642.
17. Thompson D., Muriel P., Russell D., Osborne P., Bromley A., Rowland M., et al. Economic costs of the foot and mouth disease outbreak in the United Kingdom in 2001. Rev Sci Tech 2002, 21(December (3)):675-687.
18. Fevre E.M., Bronsvoort B.M.D.C., Hamilton K.A., Cleaveland S. Animal movements and the spread of infectious diseases. Trends Microbiol 2006, 14(March (3)):125-131.
19. Yang P.C., Chu R.M., Chung W.B., Sung H.T. Epidemiological characteristics and financial costs of the 1997 foot-and-mouth disease epidemic in Taiwan. Vet Rec 1999, 145(December (25)):731-734.
20. Dunn C.S., Donaldson A.I. Natural adaption to pigs of a Taiwanese isolate of foot-and-mouth disease virus. Vet Rec 1997, 141(August (7)):174-175.
21. Sakamoto K., Kanno T., Yamakawa M., Yoshida K., Yamazoe R., Murakami Y. Isolation of foot-and-mouth disease virus from Japanese black cattle in Miyazaki Prefecture, Japan, 2000. J Vet Med Sci 2002, 64(January (1)):91-94.
22. Knowles N.J., Samuel A.R. Molecular epidemiology of foot-and-mouth disease virus. Virus Res 2003, 91(January (1)):65-80.
23. Joo Y.S., An S.H., Kim O.K., Lubroth J., Sur J.H. Foot-and-mouth disease eradication efforts in the Republic of Korea. Can J Vet Res 2002, 66(April (2)):122-124.
24. Knowles N.J., Samuel A.R., Davies P.R., Kitching R.P., Donaldson A.I. Outbreak of foot-and-mouth disease virus serotype O in the UK caused by a pandemic strain. Vet Rec 2001, 148(March (9)):258-259.
25. Pasick J. Application of DIVA vaccines and their companion diagnostic tests to foreign animal disease eradication. Anim Health Res Rev 2004, 5(2):257-262.
26. Parida S., Cox S.J., Reid S.M., Hamblin P., Barnett P.V., Inoue T., et al. The application of new techniques to the improved detection of persistently infected cattle after vaccination and contact exposure to foot-and-mouth disease. Vaccine 2005, 23(October (44)):5186-5195.